Mahesh Kumar Clinical Oncology Society of Australia Annual Scientific Meeting 2026

Abstracts this author is presenting:

• Reduction in costs with a 4-week course of moderately hypofractionation chemoradiation in unresectable stage 3 non-small cell lung cancer: a secondary analysis from the phase 2 MODERN-LUNG trial — Wednesday Poster Session